HealthEquity Inc. (NASDAQ:HQY) VP Darcy G. Mott sold 10,000 shares of the business’s stock in a transaction on Thursday, October 20th. The shares were sold at an average price of $35.37, for a total value of $353,700.00. Following the completion of the sale, the vice president now owns 88,000 shares of the company’s stock, valued at $3,112,560. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
HealthEquity Inc. (NASDAQ:HQY) opened at 34.41 on Wednesday. The firm has a market cap of $2.02 billion, a PE ratio of 88.23 and a beta of 1.62. HealthEquity Inc. has a 12-month low of $15.80 and a 12-month high of $38.80. The stock’s 50 day moving average price is $36.15 and its 200-day moving average price is $30.09.
HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.03. The company earned $44.20 million during the quarter. HealthEquity had a return on equity of 10.89% and a net margin of 15.21%. The business’s revenue was up 44.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.08 earnings per share. Equities research analysts anticipate that HealthEquity Inc. will post $0.42 earnings per share for the current fiscal year.
HQY has been the subject of several recent research reports. Zacks Investment Research downgraded HealthEquity from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 9th. Robert W. Baird boosted their price target on HealthEquity from $31.00 to $35.00 and gave the company a “neutral” rating in a research note on Wednesday, September 7th. Barrington Research boosted their price target on HealthEquity from $34.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, September 8th. SunTrust Banks Inc. restated a “buy” rating on shares of HealthEquity in a research note on Thursday, September 8th. Finally, Raymond James Financial Inc. boosted their price target on HealthEquity from $32.00 to $40.00 and gave the company an “outperform” rating in a research note on Monday, September 12th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $36.00.
Several hedge funds have recently modified their holdings of HQY. Vanguard Group Inc. increased its stake in shares of HealthEquity by 26.3% in the second quarter. Vanguard Group Inc. now owns 3,150,828 shares of the company’s stock worth $95,739,000 after buying an additional 656,849 shares during the last quarter. Loomis Sayles & Co. L P acquired a new stake in shares of HealthEquity during the second quarter worth approximately $14,237,000. Waddell & Reed Financial Inc. increased its stake in shares of HealthEquity by 59.1% in the second quarter. Waddell & Reed Financial Inc. now owns 1,008,110 shares of the company’s stock worth $30,632,000 after buying an additional 374,529 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of HealthEquity during the second quarter worth approximately $6,661,000. Finally, BlackRock Fund Advisors increased its stake in shares of HealthEquity by 8.9% in the second quarter. BlackRock Fund Advisors now owns 2,619,987 shares of the company’s stock worth $79,608,000 after buying an additional 214,955 shares during the last quarter. 90.55% of the stock is owned by institutional investors.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.